Certified by Founder Lodge
ONL Therapeutics
United States - Ann Arbor, Michigan
START UP
1 Disclosed Funding Rounds $65,000,000
0 Participating Investments
-
Founded date
2011
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to helping patients see the future. Our mission is to develop innovative therapeutics to protect and improve the
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 17 ,2024 | Series D | $65,000,000 |
Johnson & Johnson
Bios Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
XCENA | $135,000,000 | (Jun 2, 2026)
Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
SpeedLabs | $6,500,000 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)
Gray Swan | $40,000,000 | (Jun 2, 2026)
